iCAD (NASDAQ:ICAD) Share Price Crosses Above Two Hundred Day Moving Average – Here’s Why

iCAD, Inc. (NASDAQ:ICAD) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.56 and traded as high as $2.13. iCAD shares last traded at $1.95, with a volume of 253,276 shares.

Analyst Ratings Changes

Separately, StockNews.com upgraded iCAD from a “sell” rating to a “hold” rating in a research report on Thursday, November 21st.

iCAD Trading Down 1.0 %

The company has a market capitalization of $51.75 million, a P/E ratio of -15.00 and a beta of 1.43. The business’s 50-day simple moving average is $1.77 and its 200 day simple moving average is $1.56.

Institutional Trading of iCAD

A hedge fund recently raised its stake in iCAD stock. Perritt Capital Management Inc grew its stake in shares of iCAD, Inc. (NASDAQ:ICAD) by 14.2% in the second quarter, according to its most recent filing with the SEC. The fund owned 159,900 shares of the technology company’s stock after acquiring an additional 19,917 shares during the period. Perritt Capital Management Inc owned about 0.60% of iCAD worth $208,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 24.61% of the company’s stock.

iCAD Company Profile

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.